These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27132795)

  • 1. Lysosomal Acid Phosphatase Biosynthesis and Dysfunction: A Mini Review Focused on Lysosomal Enzyme Dysfunction in Brain.
    Ashtari N; Jiao X; Rahimi-Balaei M; Amiri S; Mehr SE; Yeganeh B; Marzban H
    Curr Mol Med; 2016; 16(5):439-46. PubMed ID: 27132795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue.
    Pohl S; Mitchison HM; Kohlschütter A; van Diggelen O; Braulke T; Storch S
    J Neurochem; 2007 Dec; 103(6):2177-88. PubMed ID: 17868323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal storage disorders and iron.
    Bras JM
    Int Rev Neurobiol; 2013; 110():251-75. PubMed ID: 24209442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegenerative lysosomal disorders: a continuum from development to late age.
    Nixon RA; Yang DS; Lee JH
    Autophagy; 2008 Jul; 4(5):590-9. PubMed ID: 18497567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction.
    Platt FM; Boland B; van der Spoel AC
    J Cell Biol; 2012 Nov; 199(5):723-34. PubMed ID: 23185029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomes as a therapeutic target.
    Bonam SR; Wang F; Muller S
    Nat Rev Drug Discov; 2019 Dec; 18(12):923-948. PubMed ID: 31477883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders.
    Plotegher N; Duchen MR
    Trends Mol Med; 2017 Feb; 23(2):116-134. PubMed ID: 28111024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration.
    Audano M; Schneider A; Mitro N
    J Neurochem; 2018 Nov; 147(3):291-309. PubMed ID: 29804302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundamentals of CNS energy metabolism and alterations in lysosomal storage diseases.
    McKenna MC; Schuck PF; Ferreira GC
    J Neurochem; 2019 Mar; 148(5):590-599. PubMed ID: 30144055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging the age spectrum of neurodegenerative storage diseases.
    Boland B; Platt FM
    Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):127-43. PubMed ID: 25987168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological Functions of Lysosomal Ion Channels in the Central Nervous System.
    Cen J; Hu N; Shen J; Gao Y; Lu H
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling neuronopathic storage diseases with patient-derived culture systems.
    Zunke F; Mazzulli JR
    Neurobiol Dis; 2019 Jul; 127():147-162. PubMed ID: 30790616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lysosomal ion channels in lysosome dysfunction.
    Kendall RL; Holian A
    Inhal Toxicol; 2021 Feb; 33(2):41-54. PubMed ID: 33627009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of lysosomal dysfunction as a therapeutic strategy for neurodegenerative diseases.
    Boyd RE; Valenzano KJ
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3001-5. PubMed ID: 24894562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal storage diseases as disorders of autophagy.
    Settembre C; Fraldi A; Rubinsztein DC; Ballabio A
    Autophagy; 2008 Jan; 4(1):113-4. PubMed ID: 18000397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyso-IP: Uncovering Pathogenic Mechanisms of Lysosomal Dysfunction.
    Chen C; Sidransky E; Chen Y
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches.
    Drobny A; Prieto Huarcaya S; Dobert J; Kluge A; Bunk J; Schlothauer T; Zunke F
    Biochim Biophys Acta Mol Cell Res; 2022 Jul; 1869(7):119243. PubMed ID: 35217144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases.
    Lloyd-Evans E; Platt FM
    Cell Calcium; 2011 Aug; 50(2):200-5. PubMed ID: 21724254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Storage problems in lysosomal diseases.
    Heard JM; Bruyère J; Roy E; Bigou S; Ausseil J; Vitry S
    Biochem Soc Trans; 2010 Dec; 38(6):1442-7. PubMed ID: 21118104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
    Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S
    Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.